X0306 4 2017-02-28 0000885725 BOSTON SCIENTIFIC CORP BSX 0001484186 Fitzgerald Joseph Michael 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 EVP & President, CRM Common Stock 2017-02-28 4 A 0 47782.0000 0.0000 A 159970.0000 D Common Stock 2017-02-28 4 M 0 6089.0000 0.0000 A 166059.0000 D Common Stock 2017-02-28 4 F 0 25943.0000 24.5500 D 140116.0000 D Common Stock 68589.0000 I By 401(k) Deferred Stock Units 2017-02-28 4 M 0 6089.0000 0.0000 D Common Stock 6089.0000 6090.0000 D On February 24, 2014, the reporting person was awarded a target number of performance share units under the Company's 2014 Total Shareholder Return Performance Share Program, the actual number of which to be earned by the reporting person was based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Healthcare Index over the three annual performance cycles comprising the three-year period ended December 31, 2016 and was subject to the completion of the concurrent three-year individual service period. On February 28, 2017, the number of the target performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied. Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. Balance reflects the most current data available with regard to share holdings in the Company's 401(k) Retirement Savings Plan. Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant. Reflects multiple DSU awards with independent vesting schedules. /s/ Vance R. Brown, Attorney-in-fact 2017-03-02